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Abstract 
Background: Early detection of the risk of pre-diabetes can lessen the likelihood of the development of diabetes 
mellitus. Various studies have shown a significant correlation between obesity and the incidence of pre-diabetes 
and diabetes. However, none of the studies has presented the value of fasting plasma glucose (FPG) or the oral 
glucose tolerance test (OGTT) as parameters for diagnosing pre-diabetes or diabetes. This study aimed to estimate 
the value of FPG and the OGTT to predict pre-diabetes based on body mass index (BMI). 
Methods: This cross-sectional study was conducted in Kembaran sub district, Banyumas Regency, Indonesia. The 
research sample consisted of 231 apparently healthy respondents (not showing any clinical symptoms of diabetes) 
who were underweight, normal weight, overweight and obese in terms of their BMI, and the sample was selected 
through random sampling. All samples were measured for BMI, FPG, and OGTT. Data were then analyzed with 
linear regression. 
Results: From 231 subjects, 133 (57.5%) were considered as normal, while 90 (39.0%) were diagnosed with pre-
diabetes. We were unable to predict eight (3.5%) subjects. There was a positive correlation between BMI, FPG 
and the OGTT (FPG: r0.543; p<0.01; FPG prediction: 56.800+2.232*BMI), (OGTT: r0.462; p<0.01; OGTT 
prediction: 85.231+2.202*BMI). 
Conclusions and recommendation: BMI can be utilized as the prediction of pre-diabetic occurrence; a person the 
apparently healthy but has a BMI ≥ 25kg/m2 is considered to have pre-diabetes. [Ethiop.J. Health Dev. 2019; 
33(1):38-45] 
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Background 
Diabetes mellitus (DM) has become a global health 
problem that requires attention because of the 
increasing number of sufferers. In 2015, with an 
estimated 10 million DM cases, Indonesia had the 
seventh highest number of DM cases globally, behind 
China, India, USA, Brazil, Russia and Mexico (1). The 
prevalence of diabetes in Indonesia is increasing – 
from 1.1% in 2007 to 1.5% in 2013 and increase to 
2.0% in 2018 (2–4). In the research location of this 
study, Banyumas Regency, Indonesia, in 2015 there 
were around 7.738 people suffering from DM (5). 
 
DM is often unidentified and routine blood sugar 
checks must be carried out to diagnose it (6). The 
American Diabetes Association (ADA) recommends 
that routine diabetes screening should be done at the 
age of 45, because the earlier that DM is detected, the 
quicker treatment can be given to abate the progress of 
the disease (7). 
 
One of the risk factors suspected as the cause of 
diabetes from various studies is overweight or obesity. 
National survey in 2007, the number of obese people in 
Indonesia is 19.1% and in 2013 the number of obesity 
in adults in Indonesia amounted to 15.4% and in 2018 
increased to 21.8%. The prevalence of central obesity 
(abdominal) in the Indonesian adult population in 2007 
is 26.6%, higher than the prevalence in 2007 (18.8%), 
and in 2018 increased to 31.0% (2–4)  
 
Body mass index (BMI) is the most common indicator 
utilized to measure the level of overweight and obesity 
in adults (8). From two National surveys, Study to Help 
Improve Early evaluation and management of risk 
factors Leading to Diabetes (SHIELD) 2004 and the 
National Health and Nutrition Examination Surveys 
(NHANES) 1999–2002, average BMI in diabetics was 
27.8 kg/m2 for SHIELD and 27.9 kg/m2 for NHANES. 
For each condition, more than 75% of patients had a 
BMI ≥25 kg/m2 (9), which is attributed to 
environmental factors and unhealthy lifestyles, such as 
overeating, fatty food preferences, and a lack of 
physical activity (10,11). 
 
Approximately 70% of obese patients and more than 
50% of overweight patients experience a decrease in 
glucose tolerance. According to the Nurses Health 
Study, weight gain is a strong predictor of the risk of 
Type 2 DM (12). An increase in weight of >20kg after 
the age of 18 years represents an increased risk of DM 
of up to 12 times, and 61 times greater if the BMI is 
above 35kg/m2 (13). 
 
Pre-diabetes is a warning sign before a person actually 
suffers from diabetes. Pre-diabetes itself is 
characterized by high levels of glucose or sugar in the 
blood due to insulin resistance. Insulin resistance is an 
early symptom of Type 2 diabetes. Although it is not 
yet diabetes, pre-diabetes should to be treated 
immediately, because it is possible to develop into 
diabetes within 10 years. This pre-diabetes condition 
can still be overcome by improving lifestyle. If early 
intervention is carried out, the risk of diabetes can be 
delayed or even disappear, therefore early detection is 
required in order to prevent the condition of pre-
diabetes becoming DM. 
 
Various studies have proven a significant correlation 
between obesity and the incidence of pre-diabetes and 
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diabetes (14,15). Obesity sufferers are three times more 
likely to suffer from pre-diabetes (16,17). However, 
these studies did not include the predicted value of 
fasting plasma glucose (FPG), the oral glucose 
tolerance test (OGTT), and hemoglobin A1c (HbA1c) 
as parameters for diagnosing pre-diabetes or diabetes. 
Obtaining information about predictive values of 
fasting blood sugar levels or the value of the OGTT 
based on BMI values is more beneficial than 
information on the correlation of obesity to the risk of 
pre-diabetes/diabetes. 
 
To prevent the increasing number of diabetic incidents 
in Indonesia, it is essential to identify the early 
diagnosis of pre-diabetes in individuals. To diagnose 
pre-diabetes and diabetes can be done by checking 
FPG or OGTT or HbA1c. The examination requires 
special skills, such as health workers using certain 
techniques and tools. Due to this limitation of 
examination, it is common for a person’s pre-diabetes 
to remain unidentified.  
 
Therefore, it is very important to conduct research on 
predicting the diagnosis of pre-diabetesin asimple way. 
This study aims to estimate FPG, OGTT values and 
predict pre-diabetes based on BMI measurements. 
 
Methods 
Study design:This is a cross-sectional study, which 
takes BMI asthe independent variable and FPG and 
OGTT as dependent variables (18,19). 
 
Study population and sample size: The study was 
conducted in Kembaran sub-district, Banyumas 
Regency, Indonesia, from December 2017 to August 
2018. The study population were residents of 
Kembaran and individuals selected through the 
inclusion criteria were apparently healthy(not showing 
symptoms of trias, i.e. clinical symptoms of diabetes) 
based on the results of interviews and medical records 
from Kembaran Public Health Center; aged between 
30-45 years; classified under the BMI categories of 
underweight, normal and overweight or obese; and had 
no hereditary diabetes. Samples from inclusion criteria 
were then selected randomly and divided into four 
categories equally, namely: underweight, normal, 
overweight and obese. 
 
The study design is cross-sectional. The sample size 
was the calculation formula for cross-sectional study 
(Type 1 error 5%, d=0.05 and prevalence proportion of 
obese patients was 21.8%) (20,21), the sample was 
selected through simple random sampling. The sample 
estimation obtained was 254, but the number of 
samples collected in the analysis was 231 respondents. 
Twenty-three samples were not selected in the analysis, 
some samples were not found, most of the samples 
were obese category, and some samples did not follow 
the research. 
 
Measurements: In this study, BMI was an independent 
variable, while FPG and OGTT were dependent 
variables. Respondents’ weights and heights were 
measured using weighing scales and height gauges, 
then respondents were measured for their BMI 
(underweight <18.5kg/m2, normal weight 18.5-
24.9kg/m2, overweight 25-29.9kg/m2, Class I obesity 
30-34.9kg/m2, Class II obesity 35-39.9kg/m2, Class III 
obesity ≥40kg/m2) (22,23). Next, fasting for 8-12 hours 
was carried out before performing the FPG 
measurement (normal: below 110mg/dl; impaired 
fasting glucose: between 110mg/dl and 125mg/dl; 
diabetic:126mg/dl and above) (24). Finally,the OGTT 
was carried out by giving respondents 75g of glucose 
in 250ml of water orally, and blood sugar levels were 
measured after two hours (normal: below 140mg/dl; 
impaired glucose tolerance: between 140mg/dl and 
<200mg/dl; diabetic: 200mg/dl and above). Glucose 
levels were measured using aglucometer. The pre-
diabetes diagnosis was assessed from two parameters 
of examination: FPG and OGTT (25). 
 
Statistical analysis: Data for BMI, FPG and OGGT 
were analyzed using SPSS version 21 through a simple 
linear regression analysis. Terms of reliability from 
data regression analysis were conducted inthis study by 
implementing normality, linearity and 
heteroscedasticity tests (26–28). 
 
Ethical considerations 
This study obtained approval from the health research 
ethics committee at the Universitas Muhammadiyah 
Purwokerto. The purpose of the study was explained to 
the participants before the study. All participants 
signed consent forms voluntarily. All patient data is 
kept confidential and is only used for research purposes. 
 
Results 
Characteristics of the subjects: The characteristics of 
the subjects in this study are shown in Table 1. There 
were 115 (49.8%) males and 116 (50.2%) females. The 
average age of the subjects was 39.52 ± 4.93 years old. 
In terms of BMI, 77 subjects (33%) were underweight; 
77 (33%) were normal weight; 74 (32%) were 
overweight; and three (1.3%) were Class I obese. None 
of the subjects were Class II or III obese. In total, 133 
(57.5%) subjects were diagnosed as normal, while 90 
(39.0%) subjects were diagnosed with pre-diabetes, 
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Table 1. Characteristics of the subjects 
 
Characteristic Results 
Sex   
Male  115 (49.8%) 
Female  116 (50.2%) 
Age, yr (mean, SD) 39.52±4.93 
BMI  
Underweight  77 (33%) 
Normal weight  77 (33%) 
Overweight/Pre-obesity 74 (32%) 
Class I obesity  3 (1%) 
Class II, III obesity 0 (0%) 
FPG   
Normal 114 (61%) 
Impaired fasting glucose  90 (39%) 
Diabetic 0 (0%) 
OGTT  
Normal  133 (57.6%) 
Impaired glucose tolerance  98 (42.4%) 
Diabetic 0 (0%) 
Diagnosis  
Normal 133 (57.5%) 
Pre-diabetes 90 (39.0%) 
Diabetes  0 (0%) 
Cannot be diagnosed 8 (3.5%) 
 
The underweight category of BMI obtained an average 
FPG of 91mg/dl and OGTT of 122mg/dl. Of the 77 
underweight BMI subjects, 12 subjects were diagnosed 
with pre-diabetes (FPG 110-125mg/dl and OGTT140-
199mg/dl). In the category of normal BMI subjects, the 
average FPG was 96mg/dl and the OGTT was 
129mg/dl, and 20 subjects out of 77 subjects in the 
normal BMI category were diagnosed with pre-
diabetes. In overweight BMI subjects, the average FPG 
was 114mg/dl and OGTT was 148mg/dl, and 61 
subjects out of 74 were diagnosed with pre-diabetes. In 
subjects in the BMI obese category, the average FPG 
was 116mg/dl and the OGTT was 150mg/dl. All of the 
subjects in the obese BMI category were diagnosed to 
have pre-diabetes 
 
Correlation and linear regression of BMI, FPG and 
OGTT: The results of the analysis revealed that there 
was a positive correlation between BMI and FPG (r: 
0.543, p<0.01): the higher the BMI value presented, the 
higher the FPG value obtained. BMI contributed 30% 
(r2) to the variation in FPG values, while the remaining 
70% was affected by other factors. Based on the results 
of the coefficient analysis, it was assumed that FPG 
(dependent variable) compared to BMI (independent 
variable) with the equation FPG: 56,800 + 2,232*BMI. 
 
In addition, the analysis presented a positive 
correlation between BMI and OGTT (r: 0.462, p<0.01), 
which meant that an increase of BMI value would 
affect the increase of the OGTT value. BMI value 
contributed 21% (r2) to the variation in OGTT values, 
while the rest (79%) was affected by other factors. 
Based on the coefficient analysis, we could also 
assume the OGTT value (dependent variable) based on 
the BMI (independent variable) value with the equation 
OGTT: 85,231 + 2,202*BMI. 
 
Scatter plots (linear regression) correlation between BMI and FPG and OGTT is shown in Figure 1. 
Figure 1: Scatter plots of BMI in relation to FPG and OGTT 
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The results of the residual analysis to assess the regression model can be seen in Figure 2. 
 
Figure 2: Residual plot analysis 
 
The results of residual analysis on normal probability 
plots showed that the data were normally distributed, as 
seen from the points which always follow and are close 
to a diagonal line. The analytical results of the 
normality test by Kolmogorov-Smirnov formula 
obtained p>0.05, which proved that the data were 
normally distributed. The results of linearity analysis 
through ANOVA showed p <0.05, which proved that 
the data on BMI, FPG and OGTT were linear. The 
residual results on plot versus fit presented plots were 
spread evenly above and below the 0 axis without 
forming a certain pattern. The results of 
heteroscedasticity test using the Glejser test obtained 
p>0.05, which meant that there were no symptoms of 
heteroscedasticity in the regression model, or data were 
identical. The results of the residual analysis on plot 
versus older discovered that the plot was spread evenly 
above and below the 0 axis without forming a specific 
pattern. Thus, the data were interpreted as independent 
and there was no autocorrelation (20-22). 
 
Pre-diabetic prediction: In this study, pre-diabetes 
could be predicted from BMI values using the 
equations obtained in the statistical analysis above. 
Pre-diabetes diagnosis was determined based on two 
parameters: if FPG value was between 110-125mg/dl 
and OGTT value was between 140-199mg/dl. This 
study assumed that a person with a BMI ≥25 value was 
considered to have pre-diabetes (FPG: 56,800 + 
2,232*25 = 112.6mg/dl) and (OGTT: 85,231 + 
2,202*25 = 140.28mg/dl). 
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Discussion
This study predicted the occurrence of pre-diabetes 
based on the BMI values of individuals considered to 
be healthy, and with no clinical symptoms of diabetes 
or other diseases. The results indicate that an increase 
in BMI value is positively related to an increase in FPG 
and OGTT results. 
 
The obesity level and duration were associated with an 
increased risk of pre-diabetes, which could lead to DM 
(8,29), because the increase in blood sugar levels was 
in line with the increase in BMI (30). The results of the 
study indicated that heaviera person was, the greater 
the chance of getting pre-diabetes. 
 
The role of obesity in insulin resistance is explained in 
many theories. One theory states that fat tissue is also 
an active endocrine network associated with the liver 
and muscles through the release of intermediate 
substances which later affect the role of insulin. The 
accumulation of fat tissue might end with the onset of 
insulin resistance. Insulin resistance makes glucose 
difficult to enter cells, resulting in increased levels of 
glucose in the blood (31). 
 
Obesity condition performs a significant decrease in 
adiponectin expression (32,33). Adiponectin is a 
specific cytokine in adipose tissue which has the 
structure of collagen VIII, collagen X and C1q 
complement component. Adiponectin affects insulin 
sensitivity by increasing tyrosine phosphorylation in 
insulin receptors and insulin receptor substrate in 
muscle cells. Adiponectin reduction results in a 
decrease in hepatic and peripheral insulin sensitivity 
(35). 
 
Low-grade chronic inflammation also contributes to 
the process of a metabolic syndrome characterized by 
the increased of lipopolysaccharides (LPSs), TNF-α, 
IL-6, leptin, resistin (32,36). Increased TNF-α in the fat 
tissue of obese patients presentsa direct association 
with insulin resistance (37). TNF-α enhances the 
expression regulation of protein cleavage-activating 
protein (SCAP) and improves triglyceride synthesis, 
which is likely to support the process of hepatocyte and 
pancreatic steatosis (38). Hepatocyte and pancreatic 
steatosis cause an increase in the gluconeogenesis 
process in the liver and a decrease in insulin secretion 
in the pancreas (39).  
 
Serum resistin hormone in levels were significantly 
higher in obese subjects, and were positively correlated 
with BMI (41). Increased resistin hormone (resistance 
to insulin) was a trigger for insulin resistance (42). 
 
Leptin hormone has a positive correlation with total fat 
mass, fat mass peripherals and central fat mass (38). 
Increased leptin hormone in obese people is due to cell 
resistance to this hormone, so that the body produces 
the hormone in large quantities (43). One of the 
functions of leptin is to improve metabolic rate (44). 
The reduction or resistance of leptin hormone affects 
deterioration of the body’s metabolism, resulting in a 
rise in body weight by increasing gluconeogenesis in 
the liver (31). 
 
The correlation process between obesity and the appearance of DM is indicated in Figure 4 (31,32,42–45,33–
39,41-40). 
 
Figure 4: The correlation process of obesity and diabetes mellitus 
Note: LPS = lipopolysaccharide; TNF-α= tumor necrosis factor alpha; IL-6 = interleukin-6. 
 
The results of this study predicted that a person with 
BMI≥25kg/m2 was likely to suffer from pre-diabetes, 
because the obtained equation calculation in the 
regression analysis showed BMI of 25kg/m2 would 
have an estimation of FPG value 112.6mg/dl and 
OGTT value of 140.28mg/dl, so that the FPG and 
OGTT values were beyond normal values. This study 
supports previous studies which show that individuals 
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with a BMI>25kg/m2 are at risk of developing pre-
diabetes(16,46,47). Therefore, weight management is 
important in the prevention of pre-diabetic 
development (30). 
 
Conclusion and recommendations 
This study shows that the value of someone’s FPG and 
OGTT as a basis for establishing pre-diabetes diagnosis 
can be predicted from their BMI value. Health offices 
could consider the prediction tables for the results of 
this study as material for health education for the 
community regarding obesity related to pre-diabetes. 
Further studies to assess the sensitivity and specificity 
to the results of predictions in the study are necessary 
to evaluate the extent of the accuracy of the predictions. 
 
Strengths and limitations of the study 
The results of this study make it relatively easy for 
people to estimate their FPG and OGTT values as 
markers of pre-diabetes and diabetes diagnosis without 
having to have a medical check-up. The estimated 
number of samples (273) was not in accordance with 
the results of the final sample used in this study (231), 
thus it may have reduced the level of accuracy of the 
findings. Samples in the category of Class II and III 
obesity were not obtained in the study. 
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